Skip to main content
Premium Trial:

Request an Annual Quote

Epigenomics Said to be Planning 67 Million Euro IPO

NEW YORK, July 7 (GenomeWeb News) - Epigenomics is planning an initial public offering this month that could raise as much as €67 million ($83 million), according to news reports last week.

 

According to a July 3 Bloomberg report, the Berlin-based genomics diagnostic company plans to sell 4.6 million shares for between €11.90 and €14.50, which could raise between €55 million and €67 million.

 

An Epigenomics spokeswoman declined to comment when contacted by GenomeWeb News, citing legal requirements that prohibit releasing details of the company's IPO plans to US reporters.

 

The company's stock is scheduled to start trading on the Frankfurt Stock Exchange on July 16, according to Bloomberg.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.